(Q26827726)

1 July 2019

5 references

2 October 2019

11 December 2019

22 December 2019

11 October 2020

29 April 2021

Effect of redox modulating NRF2 activators on chronic kidney disease (English)

1 reference

1 July 2019

chronic renal insufficiency

1 reference

2 October 2019

5 references

2 October 2019

11 December 2019

22 December 2019

29 May 2020

11 October 2020

1 reference

11 December 2019

1 reference

22 December 2019

1 reference

11 October 2020

nuclear factor erythroid 2-related factor 2

1 reference

29 April 2021

Bo-hyun Choi

1

1 reference

1 July 2019

Kyung-Shin Kang

series ordinal

2

1 reference

1 July 2019

Mi-Kyoung Kwak

series ordinal

3

1 reference

1 July 2019

language of work or name

1 reference

20 August 2014

7 references

1 July 2019

2 October 2019

11 December 2019

22 December 2019

29 May 2020

11 October 2020

29 April 2021

6 references

1 July 2019

2 October 2019

11 December 2019

22 December 2019

11 October 2020

29 April 2021

19

1 reference

1 July 2019

issue

8

1 reference

1 July 2019

page(s)

12727-12759

1 reference

1 July 2019

Creative Commons Attribution

copyright license

5 references

2 October 2019

11 December 2019

22 December 2019

11 October 2020

29 April 2021

0 references

Oxidative stress, anti-oxidant therapies and chronic kidney disease.

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Toxico-pharmacological perspective of the Nrf2-Keap1 defense system against oxidative stress in kidney diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Mechanisms of tubulointerstitial fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Hypertensive nephropathy: prevention and treatment recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Oxidative stress in uremia: nature, mechanisms, and potential consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Oxidative stress in uremia

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Mitochondrial dysfunction and molecular pathways of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Free radicals and antioxidants in normal physiological functions and human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Mitochondrial dysfunction accounts for aldosterone-induced epithelial-to-mesenchymal transition of renal proximal tubular epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Kidney fibrosis is independent of the amount of ascorbic acid in mice with unilateral ureteral obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Mitochondrial dysregulation and oxidative stress in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Oxidative stress and dysregulation of superoxide dismutase and NADPH oxidase in renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Increased phagocytic nicotinamide adenine dinucleotide phosphate oxidase-dependent superoxide production in patients with early chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Effect of lowering uric acid on renal disease in the type 2 diabetic db/db mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Prediabetic nephropathy as an early consequence of the high-calorie/high-fat diet: relation to oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Endogenous mitochondrial oxidative stress: neurodegeneration, proteomic analysis, specific respiratory chain defects, and efficacious antioxidant therapy in superoxide dismutase 2 null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Renal pro-inflammatory cytokine gene expression in diabetic nephropathy: effect of angiotensin-converting enzyme inhibition and pentoxifylline administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Interleukin 1-alpha and tumor necrosis factor-alpha induce oxygen radical production in mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Correlation between circulating adhesion molecule levels and albuminuria in type-2 diabetic hypertensive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

NF-kappaB: a key role in inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Transcription factor-kappa B (NF-kappa B) and renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Chronic inhibition of nuclear factor-kappaB attenuates renal injury in the 5/6 renal ablation model.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Nuclear factor-kappaB activation in diabetic rat kidney: evidence for involvement of P-selectin in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Increased glomerular and extracellular malondialdehyde levels in patients and rats with focal segmental glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Renovascular protective effects of erythropoietin in patients with chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Oxidative stress is enhanced in correlation with renal dysfunction: examination with the redox state of albumin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Manganese superoxide dismutase gene polymorphism (V16A) is associated with stages of albuminuria in Korean type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

The manganese superoxide dismutase Val16Ala polymorphism is associated with decreased risk of diabetic nephropathy in Chinese patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

The determinants of endothelial dysfunction in CKD: oxidative stress and asymmetric dimethylarginine

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Oxidative stress and inflammation are associated with adiposity in moderate to severe CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Elevated plasma F2-isoprostanes in patients on long-term hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Homocysteine, malondialdehyde and endothelial markers in dialysis patients during low-dose folinic acid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Nitric oxide metabolites, leukocyte activation markers and oxidative status in dialyzed subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Investigation of albumin properties in patients with chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Advanced glycation and lipoxidation end products: reactive carbonyl compounds-related uraemic toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Overestimation of advanced oxidation protein products in uremic plasma due to presence of triglycerides and other endogenous factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Increased oxidative damage to peripheral blood leukocyte DNA in chronic peritoneal dialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Biomarkers of inflammation and progression of chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Kidney dysfunction, inflammation, and coronary events: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Monitoring of inflammation in patients on dialysis: forewarned is forearmed

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition model

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Different Electrostatic Potentials Define ETGE and DLG Motifs as Hinge and Latch in Oxidative Stress Response

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Nrf2 protects against airway disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

The Nrf2 regulatory network provides an interface between redox and intermediary metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

The Nrf2 system as a potential target for the development of indirect antioxidants.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Accelerated DNA adduct formation in the lung of the Nrf2 knockout mouse exposed to diesel exhaust

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Disruption of Nrf2 enhances susceptibility to severe airway inflammation and asthma in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

The Nrf2/ARE pathway as a potential therapeutic target in neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Nrf2-deficient female mice develop lupus-like autoimmune nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Transcription factor Nrf2 is protective during ischemic and nephrotoxic acute kidney injury in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

The NRF2-heme oxygenase-1 system modulates cyclosporin A-induced epithelial-mesenchymal transition and renal fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

The protective role of Nrf2 in streptozotocin-induced diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Dietary cancer-chemopreventive compounds: from signaling and gene expression to pharmacological effects

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Dietary chemopreventive compounds and ARE/EpRE signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Distinct Cysteine Residues in Keap1 Are Required for Keap1-Dependent Ubiquitination of Nrf2 and for Stabilization of Nrf2 by Chemopreventive Agents and Oxidative Stress

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Potent induction of carcinogen defence enzymes with sulforaphane, a putative prostate cancer chemopreventive agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

In vivo pharmacokinetics and regulation of gene expression profiles by isothiocyanate sulforaphane in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Sulforaphane and quercetin modulate PhIP-DNA adduct formation in human HepG2 cells and hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Sulforaphane and its glutathione conjugate but not sulforaphane nitrile induce UDP-glucuronosyl transferase (UGT1A1) and glutathione transferase (GSTA1) in cultured cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

7-Methylsulfinylheptyl and 8-methylsulfinyloctyl isothiocyanates from watercress are potent inducers of phase II enzymes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Potency of Michael reaction acceptors as inducers of enzymes that protect against carcinogenesis depends on their reactivity with sulfhydryl groups

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Multitargeted cancer prevention by quercetin

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Potential toxicity of flavonoids and other dietary phenolics: significance for their chemopreventive and anticancer properties

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Activation of innate immunity system during aging: NF-kB signaling is the molecular culprit of inflamm-aging

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Nrf2-keap1 system versus NF-κB: the good and the evil in chronic kidney disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Nrf1 and Nrf2 regulate rat glutamate-cysteine ligase catalytic subunit transcription indirectly via NF-kappaB and AP-1

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Disruption of Nrf2 enhances the upregulation of nuclear factor-kappaB activity, tumor necrosis factor-α, and matrix metalloproteinase-9 after spinal cord injury in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Gliotoxin reduces the severity of trinitrobenzene sulfonic acid-induced colitis in mice: evidence of the connection between heme oxygenase-1 and the nuclear factor-kappaB pathway in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Lipopolysaccharide-induced expression of NAD(P)H:quinone oxidoreductase 1 and heme oxygenase-1 protects against excessive inflammatory responses in human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Nuclear factor kappa B is a molecular target for sulforaphane-mediated anti-inflammatory mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Comparative studies on the suppression of nitric oxide synthase by curcumin and its hydrogenated metabolites through down-regulation of IkappaB kinase and NFkappaB activation in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Triterpenoid CDDO-Me blocks the NF-kappaB pathway by direct inhibition of IKKbeta on Cys-179.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Systemic lupus erythematosus and other autoimmune diseases from endogenous and exogenous agents: unifying theme of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Nrf2 suppresses lupus nephritis through inhibition of oxidative injury and the NF-κB-mediated inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Epigallocatechin-3-gallate prevents lupus nephritis development in mice via enhancing the Nrf2 antioxidant pathway and inhibiting NLRP3 inflammasome activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Curcumin attenuates lupus nephritis upon interaction with regulatory T cells in New Zealand Black/White mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Prevention of murine lupus nephritis by targeting multiple signaling axes and oxidative stress using a synthetic triterpenoid

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Inhibitory role of the KEAP1-NRF2 pathway in TGFβ1-stimulated renal epithelial transition to fibroblastic cells: a modulatory effect on SMAD signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Involvement of Nrf2-GSH signaling in TGFβ1-stimulated epithelial-to-mesenchymal transition changes in rat renal tubular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Role of impaired Nrf2 activation in the pathogenesis of oxidative stress and inflammation in chronic tubulo-interstitial nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Antioxidant Enzymes and Lipid Peroxidation in Type 2 Diabetes Mellitus Patients with and without Nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Study of oxidative stress in patients with advanced renal disease and undergoing either hemodialysis or peritoneal dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Modulation of Nrf2 expression alters high glucose-induced oxidative stress and antioxidant gene expression in mouse mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Prevention of diabetic nephropathy in rats through enhanced renal antioxidative capacity by inhibition of the proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Potential role for Nrf2 activation in the therapeutic effect of MG132 on diabetic nephropathy in OVE26 diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Indoxyl sulfate-induced endothelial dysfunction in patients with chronic kidney disease via an induction of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Indoxyl sulfate, a uremic toxin, downregulates renal expression of Nrf2 through activation of NF-κB.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Antioxidant functions of sulforaphane: a potent inducer of Phase II detoxication enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Chemoprevention by isothiocyanates and their underlying molecular signaling mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Modulation of phase II enzymes by sulforaphane: implications for its cardioprotective potential

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Broccoli: a unique vegetable that protects mammalian hearts through the redox cycling of the thioredoxin superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

The transcription factor Nrf2 is a therapeutic target against brain inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Molecular basis for chemoprevention by sulforaphane: a comprehensive review.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Mechanistic studies of the Nrf2-Keap1 signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Protective effect of sulforaphane against cisplatin-induced mitochondrial alterations and impairment in the activity of NAD(P)H: quinone oxidoreductase 1 and γ glutamyl cysteine ligase: studies in mitochondria isolated from rat kidney and in LLC-PK1

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Sulforaphane protects against cisplatin-induced nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Sulforaphane protects kidneys against ischemia-reperfusion injury through induction of the Nrf2-dependent phase 2 enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Therapeutic potential of Nrf2 activators in streptozotocin-induced diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Prevention of diabetic nephropathy by sulforaphane: possible role of Nrf2 upregulation and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Activating Nrf-2 signaling depresses unilateral ureteral obstruction-evoked mitochondrial stress-related autophagy, apoptosis and pyroptosis in kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Grapes, wines, resveratrol, and heart health

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

New enlightenment of French Paradox: resveratrol's potential for cancer chemoprevention and anti-cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Inhibition of pattern recognition receptor-mediated inflammation by bioactive phytochemicals

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Resveratrol, a natural phenolic compound, inhibits cell proliferation and prevents oxidative DNA damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Resveratrol improves oxidative stress and protects against diabetic nephropathy through normalization of Mn-SOD dysfunction in AMPK/SIRT1-independent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Effect of resveratrol on antioxidant enzyme activities in the brain of healthy rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Resveratrol: its biologic targets and functional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Resveratrol prevents renal lipotoxicity and inhibits mesangial cell glucotoxicity in a manner dependent on the AMPK-SIRT1-PGC1α axis in db/db mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

High glucose induces renal mesangial cell proliferation and fibronectin expression through JNK/NF-κB/NADPH oxidase/ROS pathway, which is inhibited by resveratrol.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Resveratrol, a polyphenolic phytoalexin, attenuates diabetic nephropathy in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Resveratrol inhibits renal fibrosis in the obstructed kidney: potential role in deacetylation of Smad3

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Resveratrol as a therapeutic agent for renal fibrosis induced by unilateral ureteral obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Resveratrol protects diabetic kidney by attenuating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via Nrf2-Keap1 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Sirt1 resists advanced glycation end products-induced expressions of fibronectin and TGF-β1 by activating the Nrf2/ARE pathway in glomerular mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Discovery of curcumin, a component of golden spice, and its miraculous biological activities

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Curcumin and the cellular stress response in free radical-related diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Synergistic antibacterial effect of curcumin against methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Novel aspects for the application of Curcumin in chemoprevention of various cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Nephroprotective and hepatoprotective effects of curcuminoids

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Neuroprotective effect of α-mangostin and curcumin against iodoacetate-induced cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Molecular understanding of curcumin in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Curcumin ameliorates macrophage infiltration by inhibiting NF-κB activation and proinflammatory cytokines in streptozotocin induced-diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Curcumin prevents diabetes-associated abnormalities in the kidneys by inhibiting p300 and nuclear factor-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Curcumin ameliorates diabetic nephropathy by inhibiting the activation of the SphK1-S1P signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Curcumin ameliorates renal failure in 5/6 nephrectomized rats: role of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Attenuation of high-glucose-induced inflammatory response by a novel curcumin derivative B06 contributes to its protection from diabetic pathogenic changes in rat kidney and heart

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Inhibition of MAPK-mediated ACE expression by compound C66 prevents STZ-induced diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Curcumin attenuates Nrf2 signaling defect, oxidative stress in muscle and glucose intolerance in high fat diet-fed mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Curcumin induces Nrf2 nuclear translocation and prevents glomerular hypertension, hyperfiltration, oxidant stress, and the decrease in antioxidant enzymes in 5/6 nephrectomized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Curcumin reverses glomerular hemodynamic alterations and oxidant stress in 5/6 nephrectomized rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Effect of NCB-02, atorvastatin and placebo on endothelial function, oxidative stress and inflammatory markers in patients with type 2 diabetes mellitus: a randomized, parallel-group, placebo-controlled, 8-week study

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Curcumin extract for prevention of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Oral supplementation of turmeric attenuates proteinuria, transforming growth factor-β and interleukin-8 levels in patients with overt type 2 diabetic nephropathy: a randomized, double-blind and placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Antibacterial activity of leaf essential oils and their constituents from Cinnamomum osmophloeum

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Cinnamaldehyde enhances Nrf2 nuclear translocation to upregulate phase II detoxifying enzyme expression in HepG2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Anti-Inflammatory Activities of Cinnamomum cassia Constituents In Vitro and In Vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Cinnamoyl-based Nrf2-activators targeting human skin cell photo-oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Cinnamaldehyde impairs high glucose-induced hypertrophy in renal interstitial fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Ameliorative effect of the cinnamon oil from Cinnamomum zeylanicum upon early stage diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

New synthetic triterpenoids: potent agents for prevention and treatment of tissue injury caused by inflammatory and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Structure of the BTB domain of Keap1 and its interaction with the triterpenoid antagonist CDDO

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Bardoxolone methyl (BARD) ameliorates ischemic AKI and increases expression of protective genes Nrf2, PPARγ, and HO-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Coordinated induction of Nrf2 target genes protects against iron nitrilotriacetate (FeNTA)-induced nephrotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

The synthetic triterpenoid RTA dh404 (CDDO-dhTFEA) restores Nrf2 activity and attenuates oxidative stress, inflammation, and fibrosis in rats with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

A phase I first-in-human trial of bardoxolone methyl in patients with advanced solid tumors and lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Bardoxolone methyl and kidney function in CKD with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Use of xanthine oxidase inhibitor febuxostat inhibits renal interstitial inflammation and fibrosis in unilateral ureteral obstructive nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812727

Relation of structure of curcumin analogs to their potencies as inducers of Phase 2 detoxification enzymes

21 January 2018

1 reference

12 December 2020

Advanced glycation end products-cytokine-nitric oxide sequence pathway in the development of diabetic nephropathy: aminoguanidine ameliorates the overexpression of tumour necrosis factor-alpha and inducible nitric oxide synthase in diabetic rat glom

1 reference

12 December 2020

Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes

1 reference

12 December 2020

Reactive oxygen species alter gene expression in podocytes: induction of granulocyte macrophage-colony-stimulating factor

1 reference

12 December 2020

Immunohistochemical detection of hypochlorite-modified proteins in glomeruli of human membranous glomerulonephritis

1 reference

12 December 2020

Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray

1 reference

12 December 2020

Plasma F2-isoprostane levels are elevated in chronic hemodialysis patients.

1 reference

12 December 2020

The polymorphism of manganese superoxide dismutase is associated with diabetic nephropathy in Japanese type 2 diabetic patients.

1 reference

12 December 2020

National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification

1 reference

12 December 2020

Local induction of angiotensin-converting enzyme in the kidney as a mechanism of progressive renal diseases.

1 reference

12 December 2020

K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease

1 reference

12 December 2020

Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies.

1 reference

12 December 2020

DNA oxidative damage in patients with dialysis treatment

1 reference

12 December 2020

Preincubation with the proteasome inhibitor MG-132 enhances proteasome activity via the Nrf2 transcription factor in aging human skin fibroblasts

1 reference

12 December 2020

Concentrated red grape juice exerts antioxidant, hypolipidemic, and antiinflammatory effects in both hemodialysis patients and healthy subjects.

1 reference

12 December 2020

Curcumin, the active principle of turmeric (Curcuma longa), ameliorates diabetic nephropathy in rats

1 reference

12 December 2020

Oxidative stress is progressively enhanced with advancing stages of CKD

1 reference

12 December 2020

NADPH oxidase p22phox and catalase gene variants are associated with biomarkers of oxidative stress and adverse outcomes in acute renal failure

1 reference

12 December 2020

Catalase overexpression attenuates angiotensinogen expression and apoptosis in diabetic mice

1 reference

12 December 2020

Induction of reactive oxygen species from isolated rat glomeruli by protein kinase C activation and TNF-alpha stimulation, and effects of a phosphodiesterase inhibitor

1 reference

12 December 2020

The uremic solute indoxyl sulfate induces oxidative stress in endothelial cells

1 reference

12 December 2020

Action of Nrf2 and Keap1 in ARE-mediated NQO1 expression by quercetin

1 reference

12 December 2020

Possible role of tumor necrosis factor and interleukin-1 in the development of diabetic nephropathy

1 reference

12 December 2020

Comparative effects of dietary supplementation with red grape juice and vitamin E on production of superoxide by circulating neutrophil NADPH oxidase in hemodialysis patients.

1 reference

12 December 2020

Effect of Febuxostat on the Progression of Renal Disease in 5/6 Nephrectomy Rats with and without Hyperuricemia

1 reference

12 December 2020

Investigation of a novel mechanism of diabetic complications: impacts of mitochondrial reactive oxygen species

1 reference

12 December 2020

Effect of oxidative stress on antioxidant enzyme activities, homocysteine and lipoproteins in chronic kidney disease

1 reference

12 December 2020

Hyperglycemia induces oxidative and nitrosative stress and increases renal functional impairment in Nrf2-deficient mice.

1 reference

12 December 2020

Direct all-cause health care costs associated with chronic kidney disease in patients with diabetes and hypertension: a managed care perspective

1 reference

12 December 2020

Nrf2-ARE signaling pathway and natural products for cancer chemoprevention

1 reference

12 December 2020

Role of intrarenal angiotensin system activation, oxidative stress, inflammation, and impaired nuclear factor-erythroid-2-related factor 2 activity in the progression of focal glomerulosclerosis

1 reference

12 December 2020

Effect of bardoxolone methyl on kidney function in patients with T2D and Stage 3b-4 CKD

1 reference

12 December 2020

DNA damage in salivary gland tissue in patients with chronic kidney disease, measured by the comet assay

1 reference

12 December 2020

Curcumin Protects from Cardiac Reperfusion Damage by Attenuation of Oxidant Stress and Mitochondrial Dysfunction

1 reference

12 December 2020

Curcumin attenuates diabetic nephropathy by inhibiting PKC-α and PKC-β1 activity in streptozotocin-induced type I diabetic rats

1 reference

12 December 2020

Relationship between antioxidant enzyme genotype and activity and kidney function: a case-control study.

1 reference

12 December 2020

Curcumin alleviates oxidative stress, inflammation, and renal fibrosis in remnant kidney through the Nrf2-keap1 pathway

1 reference

12 December 2020

Stereological survey of the ameliorative effects of sulforaphane and quercetin on renal tissue in unilateral ureteral obstruction in rats

1 reference

12 December 2020

A story of microalbuminuria and diabetic nephropathy

1 reference

12 December 2020

Derivative of Bardoxolone Methyl, dh404, in an Inverse Dose-Dependent Manner Lessens Diabetes-Associated Atherosclerosis and Improves Diabetic Kidney Disease

1 reference

12 December 2020

mRNA expression of growth factors in glomeruli from diabetic rats

1 reference

12 December 2020

Plasma levels of IL-1 beta, TNF alpha and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients

1 reference

12 December 2020

Antioxidant enzymes activity in polymorphonuclear leukocytes in chronic renal failure

1 reference

12 December 2020

Advanced oxidation protein products as a novel marker of oxidative stress in uremia

1 reference

12 December 2020

Correlation between oxidized low density lipoproteins and von Willebrand factor in chronic renal failure

1 reference

12 December 2020

Role of lipid peroxidation, trace elements and anti-oxidant enzymes in chronic renal disease patients

1 reference

12 December 2020

Increased advanced glycation end products in atherosclerotic lesions of patients with end-stage renal disease

1 reference

12 December 2020

10.3390/MOLECULES190812727

Identifiers

DOI

1 reference

1 July 2019

OpenCitations bibliographic resource ID

3070904

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

1 July 2019

PubMed ID

25140450

1 reference

1 July 2019